spite
novel
antidiabet
drug
avail
market
type
diabet
mellitu
affect
nearli
million
peopl
usa
caus
death
global
year
given
rate
proport
affect
human
be
indispens
identifi
new
therapeut
target
control
diseas
recent
preclin
clinic
studi
suggest
attenu
activ
reninangiotensin
system
ra
could
improv
glycemia
diabet
patient
angiotensin
convert
enzym
counteract
ra
overact
degrad
angii
vasoconstrictor
ang
vasodil
decreas
increas
shed
activ
observ
progress
suggest
import
mechan
diseas
inde
restor
improv
glycemia
dbdb
angiiinfus
mice
benefici
effect
attribut
reduc
oxid
stress
express
islet
langerhan
addit
improv
blood
flow
advantag
ra
blocker
counteract
neg
effect
angii
also
increas
ang
masr
receptor
ang
produc
action
signal
cell
increas
ang
masr
signal
report
improv
insulin
sensit
glycemia
diabet
anim
altogeth
masr
axi
ra
appear
protect
strategi
restor
level
diseas
seem
promis
therapi
angiimedi
avoid
enorm
rise
preval
becom
imper
discov
novel
therapeut
intervent
order
curtail
diseas
one
novel
target
control
could
member
reninangiotensin
system
ra
system
extens
studi
context
blood
pressur
regul
howev
begin
understand
role
ra
glucos
homeostasi
increas
ra
overact
report
contribut
toward
impair
glycemia
hand
blockad
ra
shown
benefici
improv
glycemia
clinic
studi
compon
ra
fig
identifi
system
circul
also
differ
tissu
eye
brain
heart
blood
vessel
pancrea
islet
langerhan
suggest
exist
paracrin
intracrin
endocrin
ra
angiotensinii
angii
one
import
member
ra
potent
vasoconstrictor
involv
mediat
disord
hypertens
heart
failur
stroke
metabol
syndrom
angii
impair
glucos
toler
induc
insulin
resist
blunt
insulin
secret
islet
face
hyperglycemia
angii
report
associ
bodi
fat
accumul
insulin
resist
obes
patient
diabet
inde
angii
affect
insulin
secret
islet
also
advers
affect
insulin
signal
stimul
multipl
serin
phosphoryl
insulin
receptor
betasubunit
regulatori
subunit
insulin
signal
cascad
interestingli
angiimedi
detriment
effect
insulin
signal
revers
arb
exampl
irbesartan
improv
insulin
sensit
glucos
toler
skelet
muscl
insulin
resist
obes
zucker
rat
increas
protein
insulindepend
glucos
transport
express
moreov
valsartan
demonstr
improv
glycemia
enhanc
insulin
signal
pathway
kkay
mice
altogeth
enough
evid
claim
ra
play
signific
role
control
glycemia
therefor
system
target
develop
novel
therapi
homologu
ace
highli
express
kidney
heart
lung
testi
interestingli
also
report
local
glucos
regul
tissu
pancrea
includ
adipos
tissu
liver
belong
zinc
metalloproteinas
famili
ident
sequenc
human
somat
ace
region
surround
catalyt
activ
site
singl
catalyt
domain
unlik
somat
ace
two
activ
site
nand
cdomain
carboxypeptidas
cleav
singl
basic
residu
cterminu
target
peptid
angii
angi
dynorphin
desarg
apelin
apelin
degrad
angi
angii
produc
ang
ang
respect
howev
catalyt
effici
angii
much
higher
angi
suggest
convers
angii
ang
physiolog
import
reaction
vivo
ang
endogen
ligand
masr
ma
receptor
vasodil
peptid
oppos
effect
vasoconstrictor
angii
henc
seem
protect
agent
detriment
effect
mediat
overact
ra
decreas
level
angii
increas
level
ang
therapeut
properti
gain
lot
attent
given
ubiquit
role
ra
regul
variou
function
bodi
play
benefici
role
attenu
hypertens
sever
anim
model
hypertens
level
kidney
brain
protein
express
found
decreas
compar
control
group
exampl
spontan
hypertens
rat
shr
strokepron
spontan
hypertens
rat
shrsp
manifest
significantli
lower
kidney
brain
express
compar
control
rat
opin
defici
hypertens
anim
result
buildup
excess
angii
decreas
ang
predispos
anim
sever
disord
interestingli
also
play
major
role
glucos
homeostasi
laboratori
recent
report
knockout
ko
mice
significantli
higher
fast
blood
glucos
level
agematch
wildtyp
wt
litterm
moreov
niu
et
al
demonstr
ko
mice
exhibit
impair
glucos
toler
differ
age
compar
control
wt
mice
ko
mice
display
decreas
firstphas
insulin
secret
respons
glucos
challeng
impli
play
role
regul
insulin
secret
hand
overexpress
improv
islet
function
glycem
control
diabet
mice
adenovir
deliveri
human
gene
pancrea
mice
caus
pancreat
hepat
overexpress
subsequ
decreas
fast
blood
glucos
level
diabet
dbdb
mice
improv
glucos
toler
increas
islet
insulin
content
stimul
prolifer
pancreat
reduc
apoptosi
islet
earli
stage
diabet
week
old
dbdb
mice
compar
control
mice
addit
takeda
et
al
recent
report
signific
improv
glycemia
studi
report
defici
exacerb
highfat
dietmedi
impair
glycemia
mice
reduc
express
myocyt
enhanc
factor
skelet
muscl
moreov
pancreat
counteract
angiimedi
impair
glucos
toler
insulin
resist
mice
beyond
glycemia
also
report
exhibit
benefici
effect
amelior
complic
summari
report
preclin
studi
regard
consist
corrobor
hypothesi
endogen
import
regul
glycemia
propos
act
possibl
attenu
deleteri
effect
angii
vasoconstrict
fibrosi
inflamm
endoplasm
er
stress
death
pancrea
therebi
protect
critic
mass
essenti
insulin
product
fig
group
recent
show
first
time
direct
effect
insulin
secret
mous
islet
cultur
presenc
angii
angii
disrupt
function
thu
prevent
increas
insulin
releas
islet
presenc
high
glucos
concentr
hand
detriment
effect
angii
attenu
genetherapi
normal
insulin
secret
islet
expos
high
glucos
level
therapeut
effect
seem
mediat
neg
regul
angii
signal
inde
report
blunt
angii
mediat
upregul
islet
mice
treat
adenoviru
therefor
potenti
amelior
detriment
consequ
oxid
stress
blood
flow
inflamm
fibrosi
sever
group
includ
previous
report
reduc
angiimedi
oxid
stress
angii
increas
superoxid
radic
oxid
stress
induc
nadph
oxidas
product
turn
result
dysfunct
found
treatment
dramat
attenu
pancreat
oxid
stress
improv
glycemia
angiiinfus
mice
addit
show
antioxid
tempol
improv
insulin
secret
presenc
angii
mous
islet
convers
report
inhibit
masr
blockad
exacerb
angiimedi
increas
reactiv
oxygen
speci
within
renal
cell
nuclei
sheep
ang
masr
pathway
thu
appear
protect
cell
oxid
stress
therefor
reduct
oxid
stress
might
mechan
amelior
symptom
oxid
stress
report
promot
diseas
altogeth
studi
suggest
improv
function
glycemia
attenu
angiimedi
oxid
stress
report
carlsson
et
al
suggest
modul
blood
flow
islet
impact
whole
bodi
glucos
homeostasi
angii
virtu
vasoconstrict
properti
reduc
blood
flow
islet
neg
affect
insulin
secret
surpris
therapi
improv
blood
flow
pancrea
angiiinfus
mice
studi
conflict
data
suggest
role
blood
flow
islet
need
confirm
differ
dose
anim
model
ra
overact
islet
inflamm
fibrosi
significantli
contribut
toward
dysfunct
therebi
impact
glycemia
agent
decreas
islet
inflamm
fibrosi
shown
improv
glycemia
diabet
subject
benefici
action
attenu
fibrosi
inflamm
report
heart
lung
liver
role
therapi
possibl
amelior
detriment
process
islet
remain
investig
recent
studi
show
therapi
attenu
pancreat
fibrosi
suggest
attenu
collagen
gene
express
hfdfed
mice
inde
tempt
specul
potenti
abat
islet
inflamm
fibrosi
given
claim
angii
mediat
inflamm
fibrosi
islet
endoplasm
reticulum
er
stress
novel
emerg
mechan
shown
contribut
chronic
diseas
hypertens
diabet
interestingli
ra
overact
report
induc
er
stress
convers
drug
reduc
rasact
might
attenu
er
stress
hypertens
er
stress
appear
one
respons
factor
dysfunct
impair
glycemia
howev
role
angii
mediat
attenu
er
stress
respect
islet
yet
determin
express
activ
variou
tissu
decreas
time
progress
disord
hypertens
mechan
observ
reduct
diseas
remain
unknown
one
explan
diminish
level
could
shed
tissu
fig
convert
enzym
tace
sheddas
report
cleav
cellmembran
bound
therebi
remov
part
protein
contain
catalyt
domain
tissu
circul
inde
upregul
human
carotid
atherosclerot
plaqu
patient
could
respons
shed
diseas
hypothesi
current
test
laboratori
interestingli
angii
regul
express
vascular
smooth
muscl
cell
brain
adipos
tissu
pancrea
shed
provid
explan
observ
downregul
face
ra
overact
mous
islet
increas
express
attenu
treatment
suggest
modul
angii
level
impact
level
summari
base
preliminari
studi
would
logic
specul
shed
islet
could
possibl
link
ra
overact
impair
glycemia
restor
shed
appear
control
ra
activ
thu
improv
glycemia
studi
aim
investig
interact
shed
glycemia
confirm
preliminari
find
effort
increas
activ
disord
sever
approach
investig
preclin
stage
wide
util
strategi
genetherapi
approach
increas
activ
anim
model
inde
benefici
effect
genetherapi
success
investig
variou
disord
includ
group
laboratori
studi
util
either
adenoviru
lentiviru
carri
gene
increas
activ
short
day
longterm
respect
far
therapi
shown
promis
result
diabet
anim
activ
endogen
xanthenon
xnt
diminazen
acetur
dize
identifi
compound
capabl
increas
activ
counteract
overact
ra
activ
appear
benefici
attenu
hyperglycemia
well
diabet
complic
hypertens
endotheli
dysfunct
diabet
subject
thu
activ
provid
novel
avenu
control
relat
complic
human
recombin
shown
promis
result
increas
activ
control
complic
anim
recent
report
suggest
role
therapi
oppos
angiimedi
signal
diabet
nephropathi
inde
treatment
attenu
diabet
kidney
injuri
akita
mous
reduc
angiimedi
nadph
oxidas
activ
increas
ang
signal
encourag
result
provid
rational
determin
effect
glycemia
insulin
secret
given
neg
role
nadph
oxidas
angii
therefor
futur
studi
aim
confirm
benefici
role
improv
glycemia
anim
model
ace
inhibitor
complet
block
format
angii
altern
enzym
chymas
contribut
format
angii
could
mediat
hyperglycemia
arb
block
receptor
prevent
detriment
effect
angii
recent
studi
suggest
benefici
effect
olmesartan
arb
vascular
remodel
mediat
via
activ
ma
axi
ra
possibl
interplay
arb
ma
axi
suggest
import
therapi
ra
blocker
combat
hyperglycemia
induc
increas
signal
hand
act
directli
angii
irrespect
pathway
involv
product
octapeptid
thu
ensur
deplet
angii
bodi
therapi
seem
effici
ace
inhibitor
presenc
angii
still
produc
bodi
combat
angiimedi
hyperglycemia
arb
ace
inhibitor
improv
glycemia
block
ra
overact
contrast
counteract
ra
overact
also
increas
ang
masr
signal
differ
cell
type
convert
angii
ang
exert
effect
bind
masr
ang
ma
signal
tend
rescu
increas
blood
pressur
mediat
angii
ang
infus
alon
presenc
ra
overact
proven
benefici
improv
glycemia
ang
report
benefici
diabet
shr
improv
glycemia
renal
vascular
function
reduc
nadphmedi
oxid
stress
proteinuria
like
infus
ang
improv
insulin
sensit
lower
blood
pressur
rat
model
metabol
syndrom
inde
transgen
rat
exhibit
elev
system
ang
level
manifest
improv
glucos
lipid
metabol
moreov
ang
infus
amelior
diabet
complic
diabet
rat
interestingli
benefici
effect
confer
ace
inhibit
associ
increas
plasma
level
ang
shr
pregnanc
tend
elev
plasma
level
ang
women
gestat
diabet
lower
level
ang
healthi
pregnant
women
suggest
role
ang
mainten
glycemia
pregnanc
importantli
blockad
ang
receptor
dala
ang
antagonist
oppos
effect
overexpress
emphas
role
ang
function
glycemia
import
masr
illustr
studi
show
ma
knockout
mice
fvbn
background
manifest
high
blood
pressur
low
level
nitric
oxid
low
concentr
mrna
endotheli
synthas
enzym
synthes
blood
vessel
wall
genet
delet
masr
fvbn
background
also
lead
metabol
syndromelik
state
form
dyslipidemia
hyperinsulinemia
impair
glucos
toler
diminish
insulin
sensit
effect
could
relat
recent
observ
masr
locat
moreov
masr
agonist
play
cardioprotect
role
diabet
rat
also
report
amelior
extent
diabet
cardiovascular
dysfunct
rat
streptozotocininduc
diabet
summari
unlik
arb
inhibitor
mediat
favor
action
modul
two
pathway
degrad
detriment
angii
level
control
ra
activ
increas
ang
specif
g
proteincoupl
receptor
ma
mediat
benefici
effect
improv
insulin
sensit
reduc
oxid
stress
vasodil
enorm
signific
diabet
grow
epidem
proport
worldwid
preclin
studi
reveal
seem
promis
therapeut
agent
control
classic
aceangii
axi
ra
one
contribut
factor
mediat
diabet
wherea
compensatori
masr
arm
provid
novel
approach
improv
glycemia
fig
reninangiotensin
system
ace
angiotensin
convert
enzym
angiotensin
ii
type
receptor
angiotensin
ii
type
receptor
arb
angiotensin
ii
type
receptor
blocker
nep
neprilysin
ap
aminopeptidas
work
model
pathogenesi
treatment
type
diabet
counteract
detriment
effect
mediat
signal
tip
balanc
therebi
enhanc
ang
masr
signal
chhabra
et
al
page
